Zenith Laboratories Inc said company report fourth quarter loss , amount determined completion year end audit .
The company elaborate .
For third quarter ended Sept 30 , 1986 , Zenith reported loss 3,451,000 dlrs 16 ct per share , adjusted May 1986 2-for-1 stock split .
The company also said received Food Drug Administration approval market Cefadroxil , generic version antibiotic domestic sale exceeding 50 mln dlrs 1986 .
Zenith said market drug `` question relating applicability certain patent resolved .
'' Reuter & # 3 ; 